Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opening A Door To Biosimilars In The US

Sep 01 2010

Related Content

Merck's Head-long Leap into Follow-On Biologics

Dec 01 2008

Merck Likes Biosimilars, But Not ESAs

May 11 2010

Health Care Reform: For Biopharmas There Is Much To Like

Apr 01 2010

Living With REMS: The New Regulatory Model Meets Commercial Reality

Apr 01 2009

A Two Pharma Horse Race In Follow-On Biologics

Feb 01 2009

Related Companies

Merck & Co., Inc.

Teva Pharmaceutical Industries Ltd.

Novartis AG

Pfizer Inc.

Hospira, Inc.

Allergan plc

Viatris Inc.

Dr. Reddy's Laboratories Ltd.

Biocon, Ltd.

Amgen, Inc.

Roche Holding AG

Johnson & Johnson

Abbott

Novartis AG

GlycoFi Inc.

Lonza Group AG

Bristol Myers Squibb Company

AstraZeneca PLC

Eli Lilly and Company

Sanofi

Sanofi

Momenta Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

Celltrion, Inc.

Itero Biopharmaceuticals, Inc.

Merck KGaA

Additional Topics

Strategy Business Strategies Platform Technologies Regulation BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window